Insider Buying Activity Uncovered - 5 Stocks On The Rise

This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [More "Safe" Gold is Needed to Meet Growing Demand]( [See why American gold should be on every investor's radar.]( --------------------------------------------------------------- January 29, 2024 Editorial Insights Insider trading occurs when company executives or major shareholders trade stocks based on non-public information. Monitoring these trades provides insight into insiders' expectations for the company's future. For instance, significant purchases before public announcements may indicate anticipated positive news and a potential share price increase. Note: "Insider Buying" is legal stock purchasing by company directors or officers, distinct from illegal insider trading based on non-public information. It's not a crime when based on public information. Insiders, having unique insights, often buy shares when they believe the stock is undervalued. This report lists stocks recently identified with substantial insider buying. --------------------------------------------------------------- Sponsor Message [Melting Glaciers Could Uncover Once-Hidden Minerals]( glaciers are a serious worry for climate scientists. But for miners exploring the "frozen north's" Golden Triangle, melting glaciers could help locate and extract both base and precious metals that were previously untouchable. [See how a changing climate could open up new resource investing opportunities.]( --------------------------------------------------------------- [Adicet Bio, Inc.]( Ticker: [ACET]( Recent Price: $2.76 Average Analyst Price Target: $14.75 (434.42%) Market Cap: $193.30M Role Transaction Description No. of Shares Amount Date Director, >10% Owner Informative Buy Non Open Market Buy 3,125,000 $7,500,000 4 Days Ago Director, >10% Owner Informative Buy Non Open Market Buy 3,125,000 $7,500,000 4 Days Ago Recent Analyst Action: Reni Benjamin, analyst at JMP Securities, reiterates coverage on [Adicet Bio, Inc. (ACET)]( in the Healthcare sector with a Hold rating (2 weeks ago). Here are 3rd party ratings for [ACET](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Buy, Top 38% (96 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Is this AI's biggest breakthrough to date?]( the past year, AI has amazed us all with its achievements. It can predict weather, recommend winning stocks, create original art, write computer code, detect skin cancer – and, shockingly, it can do all these things better than most humans. But when you see its latest leap (revealed in on-location footage), you may want to pinch yourself! [Get the full scoop here]( --------------------------------------------------------------- [Compass Diversified]( Ticker: [CODI]( Recent Price: $22.81 Average Analyst Price Target: $29.67 (30.06%) Market Cap: $1.64B Role Transaction Description No. of Shares Amount Date Other Informative Buy Non Open Market Buy 90,000 $2,035,200 4 Days Ago Recent Analyst Action: Derek Hewett, analyst at Bank of America Securities, reiterates coverage on [Compass Diversified (CODI)]( in the Industrials sector with a Buy rating and a price target of $27 (2 months ago). Here are 3rd party ratings for [CODI](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 44% (110 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Texas Capital Bancshares, Inc.]( Ticker: [TCBI]( Recent Price: $62.68 Average Analyst Price Target: $67.40 (7.53%) Market Cap: $3.01B Role Transaction Description No. of Shares Amount Date Director Informative Buy Non Open Market Buy 9,000 $171,370 4 Days Ago Director Informative Buy Non Open Market Buy 2,000 $125,120 4 Days Ago Director Informative Buy Non Open Market Buy 12,000 $227,260 6 Days Ago Recent Analyst Action: Brock Vandervliet, analyst at UBS, reiterates coverage on [Texas Capital Bancshares, Inc. (TCBI)]( in the Financial Services sector with a Sell rating and a price target of $57 (6 days ago). Here are 3rd party ratings for [TCBI](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 32% (80 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [America's Cash Bubble Set to Burst on January 31, 2024]( the first time I’ve ever heard of… we know the exact day (and time) a bubble is going to burst. This is insane and something we only have access to because of Jason’s findings (that he’s sharing with his ultra-elite clients). To find out what the cash bubble is and why you’re vulnerable to it without even realizing... [Watch His Free Video Here]( --------------------------------------------------------------- [Olema Pharmaceuticals, Inc.]( Ticker: [OLMA]( Recent Price: $11.34 Average Analyst Price Target: $24.80 (118.69%) Market Cap: $621.09M Role Transaction Description No. of Shares Amount Date CMO Informative Buy Options Exercised and fully kept 12,400 $140,400 4 Days Ago Recent Analyst Action: Sam Slutsky, analyst at LifeSci Capital, reiterates coverage on [Olema Pharmaceuticals, Inc. (OLMA)]( in the Healthcare sector with a Buy rating and a price target of $26 (1 month ago). Here are 3rd party ratings for [OLMA](: - TipRanks.com: Buy - TradingView.com: Sell - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 38% (96 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message ["America's Icebox" to Help Solve Gold Supply Crisis?]( and Russia are the largest global gold producers. American reliance on imported minerals is at record levels, leaving us vulnerable to foreign suppliers cutting off shipments for geopolitical reasons. Experts are calling for more U.S. mining to build safe and reliable supply chains for precious and base metals. [See how investors could benefit from new Alaskan mining projects.]( --------------------------------------------------------------- [Perspective Therapeutics, Inc.]( Ticker: [CATX]( Recent Price: $0.65 Average Analyst Price Target: $1.30 (100.00%) Market Cap: $318.29M Role Transaction Description No. of Shares Amount Date CMO Informative Buy Non Open Market Buy 280,000 $137,200 4 Days Ago Director Informative Buy Non Open Market Buy 51,996 $25,478 4 Days Ago Recent Analyst Action: Yuan Zhi, analyst at B.Riley Financial, reiterates coverage on [Perspective Therapeutics, Inc. (CATX)]( in the Healthcare sector with a Buy rating and a price target of $1.2 (3 days ago). Here are 3rd party ratings for [CATX](: - TipRanks.com: Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Buy, Top 37% (94 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [What Happened to New Gold Discoveries?]( are increasingly bullish on gold, with some calling for a target of $2,500 by the end of 2024. However, the number of new gold discoveries declined by 70% over the last decade. New gold projects in attractive mining jurisdictions are needed to help fill the widening gap between supply and demand. [See why savvy investors are looking at U.S. gold projects right now.]( --------------------------------------------------------------- And there you have it. To Your Financial Freedom, The Editor InsideTraderAlerts Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( InsideTraderAlerts part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software